CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Guangdong VTR Bio-Tech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Guangdong VTR Bio-Tech Co Ltd
No. 8
Pingbei First Road
Phone: +86 7568676888p:+86 7568676888 ZHUHAI, GNG  519060  China Ticker: 300381300381
Business Summary
Guangdong VTR Bio-Tech Co Ltd is a China-based company principally engaged in biotechnology. The Company is primarily engaged in the research and development, production, sales, and services of bio-enzyme preparations, biosynthetic products, and plant extracts, and provides integrated biotechnology solutions to its customers. Bio-enzyme preparations mainly include enzymes for feed, energy, detergents, food processing, papermaking, and textiles. Biosynthetic products include pharmaceuticals, food products, feed products, cosmetics, and medical devices. Plant extracts are mainly plant extracts for animal use, including Macleaya cordata extracts and Macleaya cordata powder, as well as sanguinarine alkaloids and sanguinarine alkaloid powder. The Company mainly operates its businesses in the domestic market and overseas markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2048 Prepared feeds and feed ingredients for animals and fowls, except dog and cat
2834 Pharmaceutical preparations
2869 Industrial organic chemicals, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ShaomeiChen 62 8/1/1991 8/1/1991
Chief Financial Officer XiaopingHuang 39 4/3/2024 4/3/2024
Vice President, Director GuanchengChen 34 2/18/2025 2/22/2021
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,106 (As of 12/31/2025)
Outstanding Shares: 480,173,861 (As of 5/12/2026)
Shareholders: 19,833
Stock Exchange: SHE
Fax Number: +86 7568680252


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, August 16, 2026